Dr. Jacqueline Malekirad, MD

Dr. Malekirad practices at San Juan Capistrano Surgery Center in San Juan Capistrano, California.

Dr. Malekirad's NPI, 1972892750, was assigned on April 1, 2011. Dr. Malekirad graduated from University Of Washington School Of Medicine in 2011. Dr. Malekirad holds California license 136781.

Dr. Malekirad's primary practice is San Juan Capistrano Surgery Center, at 31001 Rancho Viejo Road, San Juan Capistrano, CA 92675. The practice phone is (323) 603-8333.

Dr. Malekirad's primary practice is San Juan Capistrano Surgery Center in San Juan Capistrano, California. Dr. Malekirad is also affiliated with MemorialCare Saddleback Medical Center. The medical group on file is MemorialCare Medical Group. Dmand AI also links Dr. Malekirad to 1 more hospital, 1 dialysis center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malekirad practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Malekirad's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Malekirad is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Malekirad's licenses on file in 3 states: California, Nevada and Vermont.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, deep vein thrombosis (DVT), lung cancer, lymphoma and multiple myeloma among the conditions Dr. Malekirad treats.

CMS data shows 26,007 Medicare services from Dr. Malekirad across 13 procedure codes in 2024, for 217 Medicare patients. Medicare paid $152,674 for them.

CMS counts 217 Medicare patients who saw Dr. Malekirad in 2024. The largest group is 65 to 74, with 97 patients. 74% of them have high cholesterol, and 72% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malekirad's median patient age at 72, with 65% women.

In 2024, Dr. Malekirad wrote 693 Medicare Part D claims for 141 patients. 76% of them were for generic drugs. CMS names the drug for 568 of them, across 19 drugs with 11 or more claims each, at $539,670 in total drug cost. In 2023, CMS named 439 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Malekirad for performance year 2024, reported as part of a group. Dr. Malekirad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malekirad as offering telehealth.

Dmand AI links 1 paper to Dr. Malekirad. Dr. Malekirad's most frequent co-authors are Jayasri G. Iyer, MD, Paul Tuan-Xuan Nghiem and Kelly Garneski Paulson, MD, PhD.

CMS Open Payments shows 518 general payments to Dr. Malekirad from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Amgen Inc. paid the most, $865.

Dmand AI lists 8 awards for Dr. Malekirad, most recently Celebrating UW Women Deserving of Recognition, Nomination Award in 2009.

Dr. Malekirad graduated from University Of Washington School Of Medicine in 2011. Dr. Malekirad is a member of ASCO and ASH.

Dr. Malekirad is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.